Related references
Note: Only part of the references are listed.A Gene Expression Signature Associated with K-Ras Addiction Reveals Regulators of EMT and Tumor Cell Survival
Anurag Singh et al.
CANCER CELL (2009)
Alterations in Genes of the EGFR Signaling Pathway and Their Relationship to EGFR Tyrosine Kinase Inhibitor Sensitivity in Lung Cancer Cell Lines
Jeet Gandhi et al.
PLOS ONE (2009)
Uniparental disomy in cancer
Musaffe Tuna et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Estimation and assessment of raw copy numbers at the single locus level
H. Bengtsson et al.
BIOINFORMATICS (2008)
Deregulated EGFR Signaling during Lung Cancer Progression: Mutations, Amplicons, and Autocrine Loops
Adi F. Gazdar et al.
CANCER PREVENTION RESEARCH (2008)
Genetic Predictors of MEK Dependence in Non-Small Cell Lung Cancer
Christine A. Pratilas et al.
CANCER RESEARCH (2008)
PIK3CA mutations and copy number gains in human lung cancers
Hiromasa Yamamoto et al.
CANCER RESEARCH (2008)
Genome-Wide Loss of Heterozygosity and Uniparental Disomy in BRCA1/2-Associated Ovarian Carcinomas
Christine S. Walsh et al.
CLINICAL CANCER RESEARCH (2008)
Novel regions of acquired uniparental disomy discovered in acute myeloid leukemia
Manu Gupta et al.
GENES CHROMOSOMES & CANCER (2008)
Sequential molecular changes during multistage pathogenesis of small peripheral adenocarcinomas of the lung
Junichi Soh et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Drug therapy: EGFR antagonists in cancer treatment
Fortunato Ciardiello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Characterizing the cancer genome in lung adenocarcinoma
Barbara A. Weir et al.
NATURE (2007)
Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays
Go Yamamoto et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
High-throughput oncogene mutation profiling in human cancer
Roman K. Thomas et al.
NATURE GENETICS (2007)
Frequent occurrence of uniparental disomy in colorectal cancer
Claus Lindbjerg Andersen et al.
CARCINOGENESIS (2007)
Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib
F. R. Hirsch et al.
ANNALS OF ONCOLOGY (2007)
SNP-array genotyping and spectral karyotyping reveal uniparental disomy as early mutational event in MSS- and MSI-colorectal cancer cell lines
R. Melcher et al.
CYTOGENETIC AND GENOME RESEARCH (2007)
SIGMA: A system for integrative genomic microarray analysis of cancer genomes
Raj Chari et al.
BMC GENOMICS (2006)
Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: Potential models for studying tumor progression-related changes
Jean-Claude Cutz et al.
CLINICAL CANCER RESEARCH (2006)
Multiple oncogenic changes (K-RASV12, p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells
M Sato et al.
CANCER RESEARCH (2006)
Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers
H Shigematsu et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay
H Asano et al.
CLINICAL CANCER RESEARCH (2006)
Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR
DW Bell et al.
NATURE GENETICS (2005)
Allele-specific amplification in cancer revealed by SNP array analysis
T LaFramboise et al.
PLOS COMPUTATIONAL BIOLOGY (2005)
Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias
J Fitzgibbon et al.
CANCER RESEARCH (2005)
Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer
F Cappuzzo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
H Shigematsu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
W Pao et al.
PLOS MEDICINE (2005)
Cancer genes and the pathways they control
B Vogelstein et al.
NATURE MEDICINE (2004)
Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins
RD Ramirez et al.
CANCER RESEARCH (2004)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Loss of heterozygosity of chromosome 12p does not correlate with KRAS mutation in non-small cell lung cancer
M Uchiyama et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Chromosome aberrations in solid tumors
DG Albertson et al.
NATURE GENETICS (2003)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Wildtype Kras2 can inhibit lung carcinogenesis in mice
ZQ Zhang et al.
NATURE GENETICS (2001)
Initial sequencing and analysis of the human genome
ES Lander et al.
NATURE (2001)
Share Paper
